Literature DB >> 20847214

Detection of the JAK2V617F mutation with the Ipsogen MutaScreen kit: absence of JAK2V617F does not mean absence of myeloproliferative neoplasm.

Hélène Peyro-Saint-Paul, Fabienne Hermitte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20847214      PMCID： PMC3173993          DOI： 10.1182/blood-2010-06-289819

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  Failure of the Ipsogen MutaScreen kit to detect the JAK2 617V>F mutation in samples with additional rare exon 14 mutations: implications for clinical testing and report of a novel 618C>F mutation in addition to 617V>F.

Authors:  Ilka Warshawsky; Frank Mularo; Carol Hren; Maureen Jakubowski
Journal:  Blood       Date:  2010-04-15       Impact factor: 22.113

2.  Identification of the JAK2 V617F mutation in chronic myeloproliferative disorders using FRET probes and melting curve analysis.

Authors:  Gurunathan Murugesan; Samer Aboudola; Hadrian Szpurka; Mary Ann Verbic; Jaroslaw P Maciejewski; Raymond R Tubbs; Eric D Hsi
Journal:  Am J Clin Pathol       Date:  2006-04       Impact factor: 2.493

Review 3.  Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms.

Authors:  A Tefferi; J W Vardiman
Journal:  Leukemia       Date:  2007-09-20       Impact factor: 11.528

4.  Clinical performance of JAK2 V617F mutation detection assays in a molecular diagnostics laboratory: evaluation of screening and quantitation methods.

Authors:  Milena Cankovic; Lisa Whiteley; Robert C Hawley; Richard J Zarbo; Dhananjay Chitale
Journal:  Am J Clin Pathol       Date:  2009-11       Impact factor: 2.493

5.  Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias.

Authors:  Wanlong Ma; Hagop Kantarjian; Xi Zhang; Chen-Hsiung Yeh; Zhong J Zhang; Srdan Verstovsek; Maher Albitar
Journal:  J Mol Diagn       Date:  2008-12-12       Impact factor: 5.568
  5 in total
  1 in total

Review 1.  Erythrocytosis: genes and pathways involved in disease development.

Authors:  Jernej Gašperšič; Aleša Kristan; Tanja Kunej; Irena Preložnik Zupan; Nataša Debeljak
Journal:  Blood Transfus       Date:  2020-12-16       Impact factor: 3.443
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.